Medications to Treat Lipid Disorders Flashcards
Biggest Strategy for lipid disorders
Decrease LDL
“Statins” HMG-CoA Reductase Inhibitors
- 1st line of therapy for lipid disorders
- decrease mortality
- Most effective at lowering LDL and total cholesterol -> Raise HDL!
Statins MOA:
- inhibit cholesterol synthesis in liver
- stimulate hepatocytes to produce more LDL receptors
- LDL receptors remove the LDL from the blood
- Most effective if given at night since cholesterol is made at night
If a diabetic patient’s LDL level is normal do they still receive statin treatment?
Yes, because statins are very effective at preventing Cardiac events
Common SE of Statins
Headache, rash, GI, memory loss, disturbance
-monitor for increased SE when statins are combined with other lipid-lowering agents
Rare but serious SE of Statins
- Allergy on record
Hepatoxicity:
- Check LFTs before use
- Contraindicated in liver disease
- can use in steatohepatitis
Myopathy/ rhabdomyolysis:
- muscle aches, tenderness, weakness
- Elevated CK levels
- Can lead to Rhabdomyolysis
Increase in incidence of cataracts
Food interactions
No grapefruit - causes toxicity
-CyP3A4 pathway
Pregnancy Category
X should not be used in pregnant women
Prototype for Statins
atorvastatin (Lipitor)
Other Statins
Lovastatin ( Mevacor)
Pravastatin (Pravechol)
Bile-Acid Sequestrants
- Biologically inert
- Bind to bile acids to form complexes that are excreted
- Since bile acids are made from cholesterol
- Work only in GI tract
Side effects of Bile- Acid Sequestrants
- Gi side effects
- Constipation, bloating, indigestion
Bile- Acid Sequestrant Prototype
colesevelam (Welchol)
-adminster with food + H2O
Cholesterol Absorption Inhibitor
- Blocks cholesterol absorption in small intestine
- also blocks cholesterol secreted in bile
Cholesterol Absorption Inhibitor SE:
equal placebo
- Watched for increased liver toxicity with statin
Cholesterol Absorption Inhibitor Prototype
Ezetimibe (Zetia)
Vytorin
ezetmibe+ sivastatin
- chlolesterol absorbed through food
- and what your body already blocks
- watch for liver toxicity
Fibric Acid Derivatives (Fibrates)
MOA: accelerate the clearance of VLDLs
- Used for high tryglycerides
- Most effective for lowering TG levels
- little to no effect on LDL cholesterol
Fibrates prototype
gemfibrozil (Lopid)
Fibrates SE
Rash and GI upset, Increased risk of gallstones, myopathy, hepatotoxicity
-Supersize me
Fibrates Drug-Drug
Warfarin: increased risk of bleeding
Statins: increased risk of rhabdo
Monoclonal Antibodies PCSK9 Inhibitors
Prototype: evolocumab (Repatha)
Others: alirocumab (Praluent)
Monoclonal Antibodies PCSK9 Inhibitors MOA:
binds to PCSK9 which block PCSK9 binding to LDL receptors. This increases LDL receptors, allowing LDL to bind to the receptors and be removed from the blood.
Monoclonal antibodies indications
-approved for familial hypercholesterolemia or atherosclerotic heart problems who maxed out statins.
Monoclonal antibodies route and SE
- adminstered SQ
SE: injection site reactions, vasculitis, rash ,uticaria. Antibody production can occur.
Other cholesterol agents
Fish Oil - taken in pill form. Evidence doesn;t support that it prevents heart disease.
Plant sterols and Sterol esters: Benecol and promise brands
Cholestin: made from rice fermented yeast